AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
58 hedge funds and large institutions have $476M invested in Aimmune Therapeutics in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $551M → $476M (-$75.3M)
Holders
58
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$15.8M | |
| 2 | +$4.62M | |
| 3 | +$4.47M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.23M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.5M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$5.08M | |
| 3 | -$2.42M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.85M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.73M |